Literature DB >> 9406228

Effects of the cholinergic system of the rat neostriatum on learning active escape in normal animals and in animals with lesions to the intralaminar thalamic nuclei.

K B Shapovalova1, E V Pominova, T A Dyubkacheva.   

Abstract

Studies were carried out into the role of the parafascicular (Pf) nuclei of the rat thalamus in learning a conditioned active escape reflex (CAER) in a T-maze, a reflex associated with discrimination of visual stimuli, and into the regulatory effect on this learning process of activation of the neostriatal cholinergic system. The following results were obtained using 57 Sprague-Dawley rats divided into a number of experimental groups: 1) bilateral microinjection of carbacholine (0.03 microgram) into the neostriatum on days 4, 5, and 6 of training produced significant (p < 0.01) increases in the proportion of correct discriminant CAER performances; 2) bilateral lesioning of the Pf nuclei led to irreversible disruption of the previously learned CAER. Rats with initially bilaterally lesioned Pf nuclei did not learn the discriminant CAER at all after 10 days of training (16 combinations), and microinjection of carbacholine into the neostriatum of these animals was ineffective. It is concluded that the integrity of the afferent input into the Pf nuclei of the thalamus is an important factor for activation of the neuronal background of the neostriatum, and is required for cholinergic activation of the neostriatum to be effective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9406228     DOI: 10.1007/bf02461935

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  15 in total

1.  [The afferent and efferent mechanisms enhancing the cholinergic activity of the neostriatum].

Authors:  K B Shapovalova
Journal:  Fiziol Zh Im I M Sechenova       Date:  1994-01

2.  Organization of the thalamostriatal projections in the rat, with special emphasis on the ventral striatum.

Authors:  H W Berendse; H J Groenewegen
Journal:  J Comp Neurol       Date:  1990-09-08       Impact factor: 3.215

Review 3.  A reappraisal of the functions of the nucleus basalis of Meynert.

Authors:  R T Richardson; M R DeLong
Journal:  Trends Neurosci       Date:  1988-06       Impact factor: 13.837

4.  Cholinergic innervation of canine thalamostriatal projection neurons: an ultrastructural study combining choline acetyltransferase immunocytochemistry and WGA-HRP retrograde labeling.

Authors:  L G Isaacson; D Tanaka
Journal:  J Comp Neurol       Date:  1988-11-22       Impact factor: 3.215

5.  [The characteristics of the participation of the neostriatal cholinergic system in regulating different forms of defensive behavior].

Authors:  K B Shapovalova; I A Zhuravin; E V Pominova; T A Diubkacheva
Journal:  Fiziol Zh Im I M Sechenova       Date:  1995-04

6.  Nigrothalamic projections in the rat as demonstrated by orthograde and retrograde tracing echniques.

Authors:  R M Clavier; S Atmadja; H C Fibiger
Journal:  Brain Res Bull       Date:  1976 Jul-Aug       Impact factor: 4.077

7.  Organization of basal ganglia inputs to the thalamus. A light and electron microscopic study in the cat.

Authors:  I A Ilinsky; K Kultas-Ilinsky; K R Smith
Journal:  Appl Neurophysiol       Date:  1982

Review 8.  Effects of medial thalamic lesions in the rat. A review and an interpretation.

Authors:  J Delacour
Journal:  Neuropsychologia       Date:  1971-06       Impact factor: 3.139

9.  Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a PHA-L study of subcortical projections.

Authors:  A F Sadikot; A Parent; C François
Journal:  J Comp Neurol       Date:  1992-01-08       Impact factor: 3.215

10.  Thalamic control of dopaminergic functions in the caudate-putamen of the rat--III. The effects of lesions in the parafascicular-intralaminar nuclei on D2 dopamine receptors and high affinity dopamine uptake.

Authors:  I C Kilpatrick; M W Jones; C J Pycock; I Riches; O T Phillipson
Journal:  Neuroscience       Date:  1986-11       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.